Company
Headquarters: Seattle, WA, United States
CEO: Dr. James N. Topper M.D., Ph.D.
$286.0 Million
USD as of July 1, 2024
Company | Market Cap (USD) |
---|---|
Berkshire Hathaway | $887.16 B |
JPMorgan | $599.29 B |
Visa | $550.38 B |
Mastercard | $416.63 B |
Bank of America | $316.02 B |
Frazier Lifesciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or related business combination with one or more businesses or entities in the biotechnology sector. The company was incorporated in 2020 and is based in Seattle, Washington.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Frazier Lifesciences Acquisition Corp has the following listings and related stock indices.
Stock: NASDAQ: FLAC wb_incandescent